These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 9085739)
21. Prevention of lethal graft-versus-host disease in mice by monoclonal antibodies directed against T cells or their subsets. I. Evidence for the induction of a state of tolerance based on suppression. Knulst AC; Tibbe GJ; Noort WA; Bril-Bazuin C; Benner R; Savelkoul HF Bone Marrow Transplant; 1994 Mar; 13(3):293-301. PubMed ID: 8199571 [TBL] [Abstract][Full Text] [Related]
22. Immunodeficiency in graft-versus-host disease. I. Mechanism of immune suppression. Wall DA; Hamberg SD; Reynolds DS; Burakoff SJ; Abbas AK; Ferrara JL J Immunol; 1988 May; 140(9):2970-6. PubMed ID: 3129505 [TBL] [Abstract][Full Text] [Related]
23. Strain difference in the radiosensitivity of immunocompetent cells and its influence on the residual host-vs-graft reaction in lethally irradiated mice grafted with semiallogeneic bone marrow. Sado T; Kamisaku H; Kubo E J Immunol; 1985 Feb; 134(2):704-10. PubMed ID: 3880789 [TBL] [Abstract][Full Text] [Related]
25. Graft-versus-leukemia effects from donor lymphocyte infusion after nonmyeloablative allogeneic bone marrow transplantation in mice. Du B; Li DP; Xu KL; Pan XY Chin Med J (Engl); 2005 Mar; 118(6):474-9. PubMed ID: 15788128 [TBL] [Abstract][Full Text] [Related]
26. Ex vivo anti-CD3 antibody-activated donor T cells have a reduced ability to cause lethal murine graft-versus-host disease but retain their ability to facilitate alloengraftment. Drobyski WR; Majewski D; Ozker K; Hanson G J Immunol; 1998 Sep; 161(5):2610-9. PubMed ID: 9725263 [TBL] [Abstract][Full Text] [Related]
27. [Effect of Ly49A transfected mouse spleen cells on graft versus host disease and graft versus leukemia after haploidentical allogeneic bone marrow transplantation in mice]. Li Y; Guo K; Chen Y; Song Z; Li J; Deng L Zhonghua Xue Ye Xue Za Zhi; 2002 Aug; 23(8):411-4. PubMed ID: 12411044 [TBL] [Abstract][Full Text] [Related]
28. Unexpected role of TNF-alpha in graft versus host reaction (GVHR): donor-derived TNF-alpha suppresses GVHR via inhibition of IFN-gamma-dependent donor type-1 immunity. Yamamoto S; Tsuji T; Matsuzaki J; Zhange Y; Chamoto K; Kosaka A; Togashi Y; Sekikawa K; Sawada K; Takeshima T; Koike T; Nishimura T Int Immunol; 2004 Jun; 16(6):811-7. PubMed ID: 15126416 [TBL] [Abstract][Full Text] [Related]
29. Murine graft-versus-host disease in an F1-hybrid model using IFN-gamma gene knockout donors. Ellison CA; Fischer JM; HayGlass KT; Gartner JG J Immunol; 1998 Jul; 161(2):631-40. PubMed ID: 9670937 [TBL] [Abstract][Full Text] [Related]
30. Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy. Johnson BD; Becker EE; LaBelle JL; Truitt RL J Immunol; 1999 Dec; 163(12):6479-87. PubMed ID: 10586039 [TBL] [Abstract][Full Text] [Related]
31. Ex vivo spermine dialdehyde treatment prevents lethal GVHD in a murine bone marrow transplantation model. Wang E; Conant JM; Li D; Visconti V; Chourmouzis E; Lau C Bone Marrow Transplant; 1990 Oct; 6(4):235-42. PubMed ID: 2085697 [TBL] [Abstract][Full Text] [Related]
32. Induction of lethal graft-versus-host disease by anti-CD137 monoclonal antibody in mice prone to chronic graft-versus-host disease. Kim W; Kim J; Jung D; Kim H; Choi HJ; Cho HR; Kwon B Biol Blood Marrow Transplant; 2009 Mar; 15(3):306-14. PubMed ID: 19203721 [TBL] [Abstract][Full Text] [Related]
34. [Experimental study of Tripterygium hypoglaucum (level) Hutch on preventing acute graft-versus-host disease in bone marrow transplantation mice]. Li S; Xu KL; Li ZY; Pan XY; Sun HY; Li DP; Cao J; Du B Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):727-30. PubMed ID: 18457261 [TBL] [Abstract][Full Text] [Related]
35. Prophylaxis of graft-versus-host disease by lentiviral-mediated expression of herpes simplex virus-thymidine kinase and ganciclovir treatment. Xu K; Zhu F; Du B; Gao F; Cheng H; Pan X Transplant Proc; 2008 Oct; 40(8):2665-9. PubMed ID: 18929831 [TBL] [Abstract][Full Text] [Related]
37. Prevention of lpr-graft-versus-host disease and transfer of autoimmune diseases in normal C57BL/6 mice by transplantation of bone marrow cells plus bones (stromal cells) from MRL/lpr mice. Miyashima S; Nagata N; Nakagawa T; Hosaka N; Takeuchi K; Ogawa R; Ikehara S J Immunol; 1996 Jan; 156(1):79-84. PubMed ID: 8598497 [TBL] [Abstract][Full Text] [Related]
38. Mixed hematopoietic chimerism for preventing graft-versus-host disease in mice receiving rat bone marrow transplantation. Pei FY; Li CF; Tang XF Di Yi Jun Yi Da Xue Xue Bao; 2003 Jul; 23(7):709-13. PubMed ID: 12865228 [TBL] [Abstract][Full Text] [Related]
39. An absence of CCR5 on donor cells results in acceleration of acute graft-vs-host disease. Welniak LA; Wang Z; Sun K; Kuziel W; Anver MR; Blazar BR; Murphy WJ Exp Hematol; 2004 Mar; 32(3):318-24. PubMed ID: 15003318 [TBL] [Abstract][Full Text] [Related]
40. Co-transplantation of bone marrow stromal cells transduced with IL-7 gene enhances immune reconstitution after allogeneic bone marrow transplantation in mice. Li A; Zhang Q; Jiang J; Yuan G; Feng Y; Hao J; Li C; Gao X; Wang G; Xie S Gene Ther; 2006 Aug; 13(15):1178-87. PubMed ID: 16598299 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]